InCarda Therapeutics   Report issue

For profit Phase 3
Founded: Palo Alto CA United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2018
NCT03539302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Chief Medical Officer at InCarda Therapeutics | InCarda Therapeutics Australia Pty Ltd. | InCarda Therapeutics, Inc.